BASF Valuation

Is BAS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BAS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: BAS (€43.04) is trading below our estimate of fair value (€109.4)

Significantly Below Fair Value: BAS is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for BAS?

Key metric: As BAS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for BAS. This is calculated by dividing BAS's market cap by their current earnings.
What is BAS's PE Ratio?
PE Ratio78.3x
Earnings€497.00m
Market Cap€38.93b

Price to Earnings Ratio vs Peers

How does BAS's PE Ratio compare to its peers?

The above table shows the PE ratio for BAS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average44x
PIDILITIND Pidilite Industries
84.9x14.1%₹1.6t
600989 Ningxia Baofeng Energy Group
18.3x38.5%CN¥115.4b
60.9x28.0%₹687.8b
4188 Mitsubishi Chemical Group
11.9x18.8%JP¥1.1t
BAS BASF
78.3x31.5%€38.9b

Price-To-Earnings vs Peers: BAS is expensive based on its Price-To-Earnings Ratio (78.3x) compared to the peer average (44x).


Price to Earnings Ratio vs Industry

How does BAS's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
BAS 78.3xIndustry Avg. 17.7xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: BAS is expensive based on its Price-To-Earnings Ratio (78.3x) compared to the European Chemicals industry average (17.7x).


Price to Earnings Ratio vs Fair Ratio

What is BAS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BAS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio78.3x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BAS's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BAS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€43.04
€53.00
+23.2%
11.1%€65.00€40.00n/a22
Nov ’25n/a
€52.52
0%
11.3%€65.00€43.00n/a21
Oct ’25€46.93
€52.25
+11.3%
13.0%€65.00€42.00n/a20
Sep ’25n/a
€53.21
0%
13.7%€70.00€42.00n/a19
Aug ’25€43.58
€53.84
+23.5%
13.1%€70.00€42.00n/a19
Jul ’25€44.58
€54.74
+22.8%
12.9%€72.00€43.00n/a19
Jun ’25€47.39
€55.74
+17.6%
12.1%€72.00€43.00n/a19
May ’25n/a
€55.68
0%
12.1%€72.00€43.00n/a19
Apr ’25n/a
€52.70
0%
13.3%€63.00€41.00n/a20
Mar ’25n/a
€50.15
0%
13.3%€62.00€39.00n/a20
Feb ’25€44.65
€48.89
+9.5%
13.8%€62.00€39.00n/a19
Jan ’25n/a
€50.26
0%
12.1%€62.00€39.00n/a19
Dec ’24n/a
€48.98
0%
13.7%€62.00€39.00n/a21
Nov ’24n/a
€49.12
0%
13.1%€62.00€37.00n/a21
Oct ’24€42.59
€50.90
+19.5%
13.4%€64.00€37.00€46.9321
Sep ’24n/a
€51.32
0%
12.3%€64.00€40.00n/a21
Aug ’24n/a
€51.46
0%
12.2%€64.00€40.00€43.5821
Jul ’24n/a
€53.61
0%
15.1%€75.00€43.00€44.5822
Jun ’24n/a
€54.05
0%
17.0%€75.00€31.03€47.3922
May ’24€48.25
€53.86
+11.6%
16.5%€72.00€31.03n/a22
Apr ’24n/a
€53.77
0%
16.0%€68.00€31.03n/a22
Mar ’24€48.43
€54.14
+11.8%
15.6%€68.00€31.03n/a22
Feb ’24n/a
€53.50
0%
15.7%€68.00€31.03€44.6522
Jan ’24n/a
€53.84
0%
17.2%€72.00€31.03n/a23
Dec ’23n/a
€54.06
0%
18.0%€75.00€31.03n/a23

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies